Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;8(3):129-133.
doi: 10.22099/mbrc.2019.34240.1421.

Repression-free utrophin-A 5'UTR variants

Affiliations

Repression-free utrophin-A 5'UTR variants

Debasish Malik et al. Mol Biol Res Commun. 2019 Sep.

Abstract

Mutation in the dystrophin gene results Duchenne Muscular Dystrophy (DMD), an X-linked fatal neuromuscular disorder. Dystrophin deficiency can be compensated by upregulation of utrophin, an autosomal homologue of dystrophin. But the expression of utrophin in adults is restricted to myotendinous and neuromuscular junctions. Therefore utrophin upregulation throughout the muscle fiber can only be achieved if we understand regulatory mechanisms behind its expression. Utrophin-A 5'UTR mediated repression of translation was reported earlier. In this article, we present evidences of two transcript variants of utrophin-A that do not confer repression to the downstream reporter ORF in mouse myoblast C2C12 cells. These repression-free variants may be targeted for utrophin upregulation.

Keywords: 5′RACE; DMD; Utrophin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Transcription Start Sites in utrophin A genomic region. (A) Schematic presentation of TSS. A and A´ are two splice variants of utrophin transcript produced from the utrophin-A promoter. The numbers after TSS represent distance of different TSS in nucleotide from start codon. (B) Positions of TSS in genomic sequence. The white arrow indicates the previously reported TSS and the grey arrow indicates the new TSS of utrophin A and A′. (C) Existence of TSS downstream of already reported TSS 490A. Utrophin-A mRNA copy number was determined with qPCR using different primer pairs. Amplicon positions are shown by black lines (X, Y, Z) in Figure 1 (A). Copy number normalized against utrophin-A coding region was plotted as mean ± SD (n=6 independent experiments). Student’s t test was used to analyze the data. The asterisk denotes P<0.0001. Difference present between copy number corresponding to amplicon X and Y confirmed subsistence of TSS between denoted amplicons. Z represents utrophin coding region amplicon used for normalisation. (D) Schematic presentation of reporter mRNAs. The utrophin-A 5′UTRs found in the 5′RACE experiment was placed at the upstream of firefly luciferase ORF in pGL3. In vitro transcribed capped, A50 tailed reporter mRNA with 5′UTRs were transfected in C2C12 cells followed by estimation of reporter activity. Renilla reporter mRNA was used as transfection control. (E) Regulatory roles of different utrophin-A 5′UTRs. Two repression-free variants were identified. Results presented as mean ±SD (n=6 independent experiments). Student’s t test was done to analyze the data. The asterisk denotes the statistically significant (P< 0.0001) difference

References

    1. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989;244:1578–1580. - PubMed
    1. Deconinck N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K, Gillis JM. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med. 1997;3:1216–1221. - PubMed
    1. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 1996;384:349–353. - PubMed
    1. Tinsley JM, Fairclough RJ, Storer R, Wilkes FJ, Potter AC, Squire SE, Powell DS, Cozzoli A, Capogrosso RF, Lambert A, Wilson FX, Wren SP, De Luca A, Davies KE. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One. 2011;6:e19189. - PMC - PubMed
    1. Miura P, Chakkalakal JV, Boudreault L, Bélanger G, Hébert RL, Renaud JM, Jasmin BJ. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Hum Mol Genet. 2009;18:4640–4649. - PubMed

LinkOut - more resources